Episode

A Path to Preventing Cognitive Impairment Due to Alzheimer Disease

Podcast
Neurology® Podcast
Published
Apr 13, 2026
Duration seconds
1690
Processing state
not_requested
Canonical source
https://neurology.libsyn.com/a-path-to-preventing-cognitive-impairment-due-to-alzheimer-disease
Audio
https://traffic.libsyn.com/secure/neurology/Neurology_Podcast_-_April_14th_2026_v2.mp3?dest-id=937793
JSON
/v1/public/podcasts/neurology-podcast-635512/episodes/a-path-to-preventing-cognitive-impairment-due-to-alzheimer-disease
Markdown
/podcast/neurology-podcast-635512/a-path-to-preventing-cognitive-impairment-due-to-alzheimer-disease.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/neurology-podcast-635512/episodes/a-path-to-preventing-cognitive-impairment-due-to-alzheimer-disease/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/neurology-podcast-635512/a-path-to-preventing-cognitive-impairment-due-to-alzheimer-disease.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr. Greg Cooper talks with Dr. Eric Reiman about emerging antibody therapies for preclinical Alzheimer disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care. Read the related article in The Lancet Neurology . Disclosures can be found at Neurology.org .